Evaluation of chromium(III) genotoxicity with cell culture and in vitro assays

The Nutritional Biochemistry of Chromium (III)

Volumn , Issue , 2007, Pages 209-224

  Stearns, Diane M ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882820755     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044453071-4/50011-4     Document Type: Chapter

References (111)

1. F. Mirasol (2000) Chromium picolinate market sees robust growth and high demand. Chem. Market Rep. 257 26.
2. F.H. Nielsen (1996) Controversial chromium: does the superstar mineral of the moun-tebanks receive appropriate attention from clinicians and nutritionists? Nutr. Today 31 226-233.
3. R.C. National Research Council (1980) Recommended Dietary Allowances, 9 th Ed. Report of the Committee on Dietary Allowances, Division of Biological Sciences, Assembly of Life Science, Food and Nutrition Board, Commission on Life Science, National Research Council. Washington, D.C.: National Academy Press
4. R.C. National Research Council (1989) Recommended Dietary Allowances, 10 th Ed. Subcommittee on the Tenth Edition of the RDAs, Food and Nutrition Board, Commission on Life Science, National Res. Washington, D.C: National Academy Press
5. V.W. Bunker, M.S. Lawson, H.T. Delvees and B.E. Clayton (1984) The uptake and excretion of chromium by the elderly. Am. J. Clin. Nutr. 39 797-802.
6. R.A. Anderson and A.S. Kozlovsky (1985) Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am. J. Clin. Nutr. 41 1177-1183.
7. E.G. Offenbacher, H. Spencer, H.J. Dowling and F.X. Pi-Sunyer (1986) Metabolic chromium balances in men. Am. J. Clin. Nutr. 44 77-82.
8. R.C. National Research Council (2002) Dietary Reference Intakes for Vitamin A, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. A Report the Panel on Micronutrients, Subcommittee on Upper Reference Levels of Nutrients and of Interpretations and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, D.C: National Academy of Sciences
9. R.A. Anderson, N. Cheng, N.A. Bryden, M.M. Polansky, N. Cheng, J. Chi and J. Feng (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 1786-1791.
10. D.W. Lamson and S.M. Plaza (2002) The safety and efficacy of high-dose chromium. Alt. Med. Rev. 7 218-235.
11. M.F. McCarty (2001) High-dose chromic picolinate treatment of type II diabetes. US Patent No. 6,329,361
12. M.B. Hansen, S. Rydin, T. Menne and J.J. Duus (2002) Quantitative aspects of contact allergy to chromium and exposure to chrome-tanned leather. Contact Dermatitis 47 127-134.
13. H.J. Gibb, P.S. Lees, P.F. Pinsky and B.C. Rooney (2000) Clinical findings of irritation among chromium chemical production workers. Am. J. Ind. Med. 38 127-131.
14. H.S. Park, H.J. Yu and K.S. Jung (1994) Occupational asthma caused by chromium. Clin. Exp. Allergy 24 676-681.
15. P. Bright, P.S. Burge, S.P. O'Hickey, P.F. Gannon, A.S. Robertson and A. Boran (1997) Occupational asthma due to chrome and nickel electroplating. Thorax 52 28-32.
16. R.P. Wedeen and L.F. Qian (1991) Chromium-induced kidney disease. Environ. Health Perspect. 92 71-74.
17. Y. Loubieres, A. de Lassence, M. Bernier, A. Viellard-Baron, J.M. Schmitt, B. Page and F. Jardin (1999) Acute, fatal, oral chromic acid poisoning. J. Toxicol. Clin. Toxicol. 37 333-336.
18. A. Stift, J. Fridl, F. Langle, G. Berlakovich, R. Steininger and F. Muhlbacher (2000) Successful treatment of a patient suffering from severe acute potassium dichromate poison-ing with liver transplantation. Transplantation 69 2454-2455.
19. A.R.C.I.A.R.C. International Agency for Research on Cancer IARC (1990) Chromium and chromium compounds. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Chromium, Nickel and Welding Lyon France: International Agency for Research on Cancer 49-256.
20. T.P. National Toxicology Program (2005) Chromium Hexavalent Compounds. 11 th Report on Carcinogens Washington, D.C: Department of Health and Human Services
21. N. Satoh, S. Fukuda, M. Takizawa, Y. Furuta, M. Kashiwamura and Y. Inuyama (1994) Chromium-induced carcinoma in the nasal region. A report of four cases. Rhinology 32 47-50.
22. K.W. Jennette (1979) Chromate metabolism in liver microsomes. Biol. Trace Elem. Res. 1 55-62.
23. I. Mulyani, A. Levina and P.A. Lay (2004) Biomimetic oxidation of chromium (III) : Does the antidiabetic activity of chromium (III) involve carcinogenic chromium (VI) ? Andew. Chem. Int. Ed. Engl. 27 4504-4507.
24. J.M. LaValle (1991) Mechanisms of toxicity/carcinogenicity and Superfund decisions. Environ. Health Perspect. 92 127-130.
25. J.L. Durant, J. Chen, H.F. Hemond and W.G. Thilly (1995) Elevated incidence of childhood leukemia in Woburn, Massachusetts: IEHS Superfund Basic Research Program searches for causes. Environ. Health Perspect. 103(Suppl. 6), 93-98.
26. R.M. Fay and M.M. Muntaz (1996) Development of a priority list of chemical mixtures occurring at 1188 hazardous waste sites, using the HazDat database. Food Chem. Toxicol. 34 1163-1165.
27. J.A. Fagliano, J. Savrin, I. Udasin and M. Gochfeld (1997) Community exposure and medical screening near chromium waste sites in New Jersey. Regul. Toxicol. Pharmacol. 26 S13-S22
28. R. Renner (2004) Huge chromium plume threatens Colorado River. Environ. Sci. Technol. 38 178A.
29. R. Renner (2003) Allegations of manipulation lead to withdrawal of Cr (VI) report. Environ. Sci. Technol. 37 276A-277A.
30. M.G. Steinpress and A.C. Ward (2001) The scientific process and Hollywood: the case of hexavalent chromium. Ground Water 39 321-322.
31. T.J. O'Brien, S. Ceryak and S.R. Patierno (2003) Complexities of chromium car-cinogenesis: Role of cellular response, repair and recovery mechanisms. Mutat. Res. 533 3-36.
32. A. Zhitkovich (2005) Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium (VI). Chem. Res. Toxicol. 18 3-11.
33. D.M. Stearns, J.J. BelBruno and K.E. Wetterhahn (1995) A prediction of Cr (III) accumulation in humans from ingestion of Cr dietary supplements. FASEB J. 9 1650-1657.
34. J.K. Speetjens, R.A. Collins, J.B. Vincent and S.A. Woski (1999) The nutritional supplement chromium (III) tris (picolinate) cleaves DNA. Chem. Res. Toxicol. 12 483-487.
35. C.C. Ramirez, D.G. Federman and R.S. Kirsner (2005) Skin cancer as an occupational disease: The effect of ultraviolet and other forms of radiation. Int. J. Dermatol. 44 95-100.
36. IARC working group on the evaluation of carcinogenic risks to humans: Ionizing radiation, Part I, X-gamma-radiation and neutrons. Lyn, France, 26 May-2 June 1. (Part I) IARC Monogr. Eval. Carcinogen. Risks Hum. 75 1-448. (No Authors)
37. F.X. Bosch, J. Ribes, R. Cleries and M. Diaz (2005) Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9 191-211.
38. M.L. Gatza, C. Chandhasin, R.I. Ducu and S.J. Marriott (2005) Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation. Environ. Mol. Mutagen. 45 304-325.
39. A. Leodolter, M. Naumann and P. Malfertheiner (2004) Prevention of gastric cancer by Helicobacter pylori eradication. Dig. Dis. 22 313-319.
40. M.D. Voigt (2005) Alcohol in hepatocellular cancer. Clin. Liver. Dis. 9 151-169.
41. J.H. Williams, T.D. Phillips, P.E. Jolly, J.K. Stiles, C.M. Jolly and D. Aggarwal (2004) Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 80 1106-1122.
42. M. Costa (2003) Potential hazards of hexavalent chromate in our drinking water. Toxicol. Appl. Pharamacol. 188 1-5.
43. W. Xue and D. Warshawsky (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol. Appl. Pharmacol. 206 73-93.
44. J.M. Auerbach and J.M. Robson (1946) Chemical production of mutations. Nature 157 302.
45. P.D. Lawley (1966) Effects of some chemical mutagens and carcinogens on nucleic acids. Prog. Nucleic Acid Res. Mol. Biol. 5 89-131.
46. C. Auerbach (1967) The chemical production of mutations. The effect of chemical mutagens on cells and their genetic material is discussed. Science 158 1141-1147.
47. J. McCann and B.N. Ames (1976) Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion. Proc. Natl. Acad. Sci. USA 73 950-954.
48. J.H. Weisburger (1999) Carcinogenicity and mutagenicity testing, then and now. Mutat. Res. 437 105-112.
49. J.T. MacGregor, D. Casciano and L. Muller (2000) Strategies and testing methods for identifying mutagenic risks. Mutat. Res. 455 3-20.
50. D.J. Kirkland (Eds) (1994) The “International Workshop on Standardization of Genotoxicity Test Procedures Mutation Research 312 3 195-321.
51. D.J. Kirkland (Eds) (2000) The International Workshop on Genotoxicity Test Procedures Environmental and Molecular Mutagenesis volume 35 159-263. 3
52. L. Muller, Y. Kikuchi, G. Probst, L. Schechtman, H. Shimada, T. Sofuni and D. Tweats (1999) ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat. Res. 436 195-225.
53. K.L. Dearfield, M.C. Cimino, N.E. McCarroll, I. Mauer and L.R. Valcovic (2002) Genotoxicity risk assessment: A proposed classification strategy. Mutat. Res. 521 121-135.
54. FDA/CFSAN (2004) Redbook 2000 Toxicological principles for the Safety Assessment of Food Ingredients.
55. G. Brambilla and A. Martelli (2004) Failure of the standard battery of short-term tests in detecting some rodent and human carcinogens. Toxicology 196 1-19.
56. R.D. Snyder and J.W. Green (2001) A review of the genotoxicity of marketed pharma-ceuticals. Mutat. Res. 488 151-169.
57. D.M. Maron and B.N. Ames (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 173-215.
58. P. Gee, D.M. Maron and B.N. Ames (1994) Detection and classification of mutagens: a set of base-specific Salmonella tester strains. Proc. Natl. Acad. Sci. USA 91 11606-11610.
59. K. Mortelmans and E. Zeiger (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 455 29-60.
60. T.P. National Toxicology Program (2005) 11 th Report on Carcinogens Washington, D.C: Department of Health and Human Services
61. F.L. Petrilli and F.S. De Flora S. (1977) Toxicity and mutagenicity of hexavalent chromium on Salmonella typhimurium. Appl. Environ. Microbiol. 33 805-809.
62. W.W. Tso and W.P. Fung (1981) Mutagenicity of metallic cations. Toxicol. Lett. 8 195-200.
63. F.S. De Flora S., A. Camoirano, P. Zanacchi and C. Bennicelli (1984) Mutagenicity testing with TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strains. Mutat. Res. 134 159-165.
64. A. Leonard (1988) Mechanisms in metal genotoxicity: The significance of in vitro approaches. Mutat. Res. 198 321-326.
65. J.C. Codina, C. Perez-Torrente, A. Perez-Garcia, F.M. Cazorla and A. de Vicente (1995) Comparison of microbial tests for the detection of heavy metal genotoxicity. Arch. Environ. Contam. Toxicol. 29 260-265.
66. F.Z. Arrouijal, H.F. Hildebrand, H. Vophi and D. Marzin (1990) Genotoxic activity of nickel subsulphide alpha-Ni 3S 2. Mutagenesis 5 583-589.
67. K. Kuroda, G. Endo, A. Okamoto, Y.S. Yoo and S. Horiguchi (1991) Genotoxicity of beryllium, gallium and antimony in short-term assays. Mutat. Res. 264 163-170.
68. F.L. Petrilli and S. de Flora (1978) Oxidation of inactive trivalent chromium to the mutagenic hexavalent form. Mutat. Res. 58 167-173.
69. K.D. Sugden, R.B. Burris and S.J. Rogers (1990) An oxygen dependence in chromium mutagenesis. Mutat. Res. 244 239-244.
70. K.D. Sugden, R.D. Geer and S.J. Rogers (1992) Oxygen radical-mediated DNA damage by redox-active Cr (III) complexes. Biochemistry 31 11626-11631.
71. A.G. Knudson (2001) Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 1 157-162.
72. S. Bonassi, A. Znaor, H. Norppa and L. Hagmar (2004) Chromosomal aberrations and risk of cancer in humans: An epidemiologic perspective. Cytogenet. Genome Res. 104 376-382.
73. D.G. Albertson, C. Collins, F. McCormick and J.W. Gray (2003) Chromosome aberra-tions in solid tumors. Nature Genet. 34 369-376.
74. M.A. Bender, H.G. Griggs and P.L. Walker (1973) Mechanisms of chromosomal aberration production. I. Aberration induction by ultraviolet light. Mutat. Res. 20 387-402.
75. M.A. Bender, J.S. Bedford and J.B. Mitchell (1973) Mechanisms of chromosomal aberration production. II. Aberrations induced by 5-bromodeoxyuridine and visible light. Mutat. Res. 20 403-416.
76. J.M. Ishidate Jr.M., M.C. Harnois and T. Sofuni (1988) A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell culture. Mutat. Res. 195 151-213.
77. A.D. Mitchell, A.E. Auletta, D. Clive, P.E. Kirby, M.M. Moore and B.C. Myhr (1997) The L5178Y/tk+/-mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U. S. Environmental Protection Agency Gene-Tox Progam. Mutat. Res. 394 177-303.
78. R.R. Newbold (2004) Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol. Appl. Pharmacol. 199 142-150.
79. R. Desjardins, M. Fournier, F. Denizeau and K. Krzystyniak (1992) Immunosuppression by chronic exposure to N-nitrosodimethylamine (NDMA) in mice. J. Toxicol. Environ. Health 37 351-361.
80. P.P. Simeonova and M.I. Luster (2000) Mechanisms of arsenic carcinogenicity: Genetic or epigenetic mechanisms. J. Environ. Pathol. Toxicol. Oncol. 19 281-286.
81. M.P. Waalkes (2003) Cadmium carcinogenesis. Mutat. Res. 533 107-120.
82. G.W. Evans and D.J. Pouchnik (1993) Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 49 177-187.
83. C.L. Broadhurst, W.F. Schmidt, J.B. Reeves III, M.M. Polansky, K. Gautschi and R.A. Anderson (1997) Characterization and structure by NMR and FTIR spectroscopy, and molecular modeling of chromium (III) picolinate and nicotinate complexes utilized for nutritional supplementation. J. Inorg. Biochem. 66 119-130.
84. S. Lanca, A. Alves, A.I. Vieira, J. Barata, J. de Freitas and A. de Carvalho (2002) Chromium-induced toxic hepatitis. Eur. J. Int. Med. 13 518-520.
85. D.M. Stearns, J.P. Wise, S.R. Sr.Patierno and K.E. Wetterhahn (1995) Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9 1643-1649.
86. D. Bagchi, S.J. Stohs, B.W. Downs, M. Bagchi and H.G. Preuss (2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180 5-22.
87. V. Bianchi, L. Celotti, G. Lanfranchi, F. Majone, G. Marin, A. Montaldi, G. Sponza, G. Tamino, P. Venier, A. Zantedeschi and A.G. Levis (1983) Genetic effects of chromium compounds. Mutat. Res. 117 279-300.
88. D.M. Stearns, S.M. Silveira, K.K. Wolf and A.M. Luke (2002) Chromium (III) tris (picolinate is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutat. Res. 513 135-142.
89. W. Yu, M.A. Sipowicz, D.C. Haines, L. Birely, B.A. Diwan, C.W. Riggs, K.S. Kasprzak and L.M. Anderson (1999) Preconception urethane or chromium (III) treatment of male mice: multiple neoplastic and non-neoplastic changes in offspring. Toxicol. Appl. Pharmacol. 158 161-176.
90. R.Y. Cheng, W.G. Alvord, D. Powell, K.S. Kasprzak and L.M. Anderson (2002) Microarray analysis of altered gene expression in the TM4 Sertoli-like cell line exposed to chromium (III) chloride. Reprod. Toxicol. 16 223-236.
91. R.Y. Cheng, W.G. Alvord, D. Powell, K.S. Kasprzak and L.M. Anderson (2002) Increased serum corticosterone and glucose in offspring of chromium (III) -treated male mice. Environ. Health Perspect. 110 801-804.
92. R.Y. Cheng, T. Hockman, E. Crawford, L.M. Anderson and Y.H. Shiao (2004) Epigenetic and gene expression changes related to transgenerational carcinogenesis. Mol. Carcinog. 40 1-11.
93. L. Jacquamet, Y. Sun, J. Hatfield, W. Gu, S.P. Cramer, W. Crowder, G.A. Lorigan, J.B. Vincent and J.M. Latour (2003) Characterization of chromodulin by X-ray absorption and electron paramagnetic resonance spectroscopies and magnetic susceptibility measure-ments. J. Am. Chem. Soc. 125.
94. L. Jacquamet, Y. Sun, J. Hatfield, W. Gu, S.P. Cramer, W. Crowder, G.A. Lorigan, J.B. Vincent and J.M. Latour (2003) Characterization of chromodulin by X-ray absorption and electron paramagnetic resonance spectroscopies and magnetic susceptibility measure-ments. J. Am. Chem. Soc. 774-780.
95. C.M. Davis, A.C. Royer and J.B. Vincent (1994) Synthetic multinuclear chromium assembly activates insulin receptor kinase activity: Functional model for low-molecular-weight chromium-binding-substance. Inorg. Chem. 36 5316-5320.
96. J.K. Speetjens, A. Parand, M.W. Crowder, J.B. Vincent and S.A. Woski (1999) Low-molecular weight chromium-binding substance and biomimetic [Cr 3O (O 2CCH 2CH 3) 6 (H 2O) 3] + do not cleave DNA under physiologically-relevant conditions. Polyhedron 18 2617-2624.
97. A. Parand, A.C. Royer, T.R. Cantrell, M. Weitzel, N. Memon, J.B. Vincent and M.W. Crowder (1998) DNA nicking by a trinuclear chromium complex. Inorg. Chim. Acta 268 211-219.
98. Evans G.W. Dietary supplementation with essential metal picolinates U.S. Patent 4,315,927
99. G.W. Evans and D.J. Pouchnik (1993) Composition and biological activity of chromium-pyridine carboxylate complexes,. J. Inorg. Biochem. 49 177-187.
100. D.M. Stearns and W.H. Armstrong (1992) Mononuclear and binuclear chromium picol-inate complexes. Inorg. Chem. 31 5178-5184.
101. M.J. Armstrong, J.P. Gara, R. Gealy R.3rd, S.K. Greenwood, C.A. Hilliard, G.M. Laws and S.M. Galloway (2000) Induction of chromosome aberrations in vitro by phe-nolphthalein: Mechanistic studies. Mutat. Res. 457 15-30.
102. R. Gudi, R.S. Slesinski, J.J. Clarke and R.H. San (2005) Chromium picolinate does not produce chromosome damage in CHO cells. Mutat. Res. 587 140-146.
103. J.K. Speetjens, R.A. Collins, J.B. Vincent and S.A. Woski (1999) The nutritional supplement chromium (III) tris (picolinate) cleaves DNA. Chem. Res. Toxicol. 12 483-487.
104. R.S. Slesinski, J.J. Clarke, R.H.C. San and R. Gudi (2005) Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat. Res. 585 86-95.
105. Z.W. Yu and P.J. Quinn (1994) Dimethyl sulphoxide: A review of its applications in cell biology. Biosci. Rep. 14 259-281.
106. D.D.D. Hepburn, J. Xiao, S. Bindom, J.B. Vincent and J. O'Donnell (2003) Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 100 3766-3771.
107. P. Whittaker, R.H.C. Sans, J.J. Clarke, H.E. Seifried and V.C. Dunkel (2005) Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food Chem. Toxicol. 43 1619-1625.
108. V.H. Coryell and D.M. Stearns (2006) Molecular analysis of hprt mutations induced by chromium picolinate in CHO AA8 cells,. Mutat. Res. 610 114-123.
109. Z. Xu, Y. Yu, J.L. Schwartz, M.L. Meltz and A.W. Hsie (1995) Molecular nature of spontaneous mutations at the hypoxanthine-guanine phosphoribosyltransferase (hprt) locus in Chinese hamster ovary cells. Environ. Mol. Mutagen. 26 127-138.
110. A.R. Jeffcoat (2002) [ 14C] Chromium picolinate monohydrate: Disposition and metabolism in rats and mice. Technical Report RTI/64U-6855/15P Research Triangle Institute, Research Triangle Park, NC
111. D.D.D. Hepburn and J.B. Vincent (2002) In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chem. Res. Toxicol. 15 93-100.